🔗 Visit the ClinicalTrials.gov page for NCT00076102
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Malignant peripheral nerve sheath tumours in neurofibromatosis 1. | J Med Genet | 2002 | 5.06 |
| 2 | Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. | Neuro Oncol | 2014 | 1.66 |
| 3 | Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. | J Clin Invest | 2000 | 1.56 |
| 4 | Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. | Drug Des Devel Ther | 2015 | 1.33 |
| 5 | Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone. | Int J Immunopharmacol | 1998 | 0.91 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |